Protein kinase G may exert pro-degradation inhibition on nitric oxide synthase

Theresa Adebola John1

  • 1Department of Pharmacology, Lagos State University College of Medicine, Lagos, Nigeria. theresaadebola@yahoo.com

Insights

Protein kinase G (PKG) activation promotes the degradation of nitric oxide synthase (NOS) in endothelial cells. This study reveals that PKG triggers NOS carboxy-terminal deletion and fragmentation, suggesting a role in enzyme clearance after activation.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Physiology

Background:

  • Nitric oxide synthase (NOS) activity is regulated by protein-protein interactions.
  • Protein kinase G (PKG) is known to inhibit activated NOS in endothelial cells.
  • Previous work suggested PKG phosphorylation terminates NOS activity.

Purpose of the Study:

  • To investigate whether PKG activation increases the breakdown of NOS.
  • To elucidate the mechanism by which PKG modulates NOS activity and stability.

Main Methods:

  • Diamino-fluorescein fluorescence spectrometry for real-time nitric oxide (NO) production measurement.
  • Fluorescence-activated cell sorting (FACS) analysis for NOS carboxy-terminal labeling.
  • Western blot analysis to detect NOS fragments and phosphorylation.

Main Results:

  • PKG activator 8-Br-cGMP dose-dependently decreased NO production.
  • PKG inhibitors increased basal NO production, which was abrogated by 8-Br-cGMP.
  • FACS and Western blot showed 8-Br-cGMP induced NOS carboxy-terminal deletion and N-terminal phosphorylation, generating 60, 50, and 35 kDa fragments.

Conclusions:

  • PKG activation leads to NOS degradation, indicated by carboxy-terminal deletion and fragmentation.
  • PKG acts as a post-activation inhibitor of NOS, potentially facilitating the clearance of the enzyme.
  • This degradation pathway may be crucial for regulating NOS function in endothelial cells.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...